C
Cellulora develops a novel, cellulose-based material for soft tissue repair designed as an injectable, long-term filler. This patented technology forms a stable, chemically crosslinked hydrogel upon injection that matches autologous tissue biocompatibility. The material provides immediate volumizing effects, maintains structural stability long-term, and is selectively reversible via enzymatic treatment.
Updated 2 months ago
Funding
Funding not disclosed
Funding rounds are not available yet.
Founders
Founder details are not available yet.
Product
Features
- Cellulora develops a novel, cellulose-based material for soft tissue repair designed as an injectable, long-term filler. This patented technology forms a stable, chemically crosslinked hydrogel upon injection that matches autologous tissue biocompatibility. The material provides immediate volumizing effects, maintains structural stability long-term, and is selectively reversible via enzymatic treatment.